Compare Stocks: EHAB, PGNY, CLOV, and ADUS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$116.46 +2.5%	$103.02	$87.95 ▼ $124.43	$2.12B	0.87	251,015 shs	284,805 shs
CLOV Clover Health Investments	$4.14 -3.0%	$4.62	$1.58 ▼ $5.59	$2.25B	2.47	4.38 million shs	4.44 million shs
EHAB Enhabit	$13.80	$13.79	$6.47 ▼ $14.22	$706.97M	1.26	1.05 million shs	1.38 million shs
PGNY Progyny	$31.37 -0.3%	$28.93	$16.10 ▼ $33.06	$2.47B	1.01	1.06 million shs	641,815 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-2.68%	-4.66%	+8.07%	+17.61%	+6.26%
CLOV Clover Health Investments	-1.39%	-1.61%	-18.82%	+59.33%	+48.26%
EHAB Enhabit	0.00%	0.00%	0.00%	+0.18%	+107.99%
PGNY Progyny	-0.16%	+2.34%	+4.17%	+68.34%	+35.81%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$116.46 +2.5%	$103.02	$87.95 ▼ $124.43	$2.12B	0.87	251,015 shs	284,805 shs
CLOV Clover Health Investments	$4.14 -3.0%	$4.62	$1.58 ▼ $5.59	$2.25B	2.47	4.38 million shs	4.44 million shs
EHAB Enhabit	$13.80	$13.79	$6.47 ▼ $14.22	$706.97M	1.26	1.05 million shs	1.38 million shs
PGNY Progyny	$31.37 -0.3%	$28.93	$16.10 ▼ $33.06	$2.47B	1.01	1.06 million shs	641,815 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-2.68%	-4.66%	+8.07%	+17.61%	+6.26%
CLOV Clover Health Investments	-1.39%	-1.61%	-18.82%	+59.33%	+48.26%
EHAB Enhabit	0.00%	0.00%	0.00%	+0.18%	+107.99%
PGNY Progyny	-0.16%	+2.34%	+4.17%	+68.34%	+35.81%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	2.73	Moderate Buy	$130.88	12.38% Upside
CLOV Clover Health Investments	2.00	Hold	$4.25	2.66% Upside
EHAB Enhabit	2.11	Hold	$13.57	-1.66% Downside
PGNY Progyny	2.85	Moderate Buy	$33.25	5.99% Upside

Current Analyst Ratings Breakdown

Latest EHAB, PGNY, CLOV, and ADUS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2026	ADUS Addus HomeCare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$130.00 ➝ $134.00
7/28/2026	PGNY Progyny	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$27.00 ➝ $34.00
7/28/2026	PGNY Progyny	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$27.00 ➝ $34.00
7/24/2026	ADUS Addus HomeCare	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
7/24/2026	PGNY Progyny	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$30.00 ➝ $40.00
7/22/2026	PGNY Progyny	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$38.00
7/21/2026	CLOV Clover Health Investments	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.20 ➝ $5.50
7/21/2026	PGNY Progyny	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$30.00 ➝ $36.00
7/13/2026	PGNY Progyny	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$30.00 ➝ $35.00
7/9/2026	ADUS Addus HomeCare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
7/8/2026	ADUS Addus HomeCare	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$92.00 ➝ $96.00

(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.42B	1.53	$6.65 per share	17.50	$61.51 per share	1.89
CLOV Clover Health Investments	$1.92B	1.13	N/A	N/A	$0.59 per share	7.02
EHAB Enhabit	$1.06B	0.67	$1.96 per share	7.04	$11.30 per share	1.22
PGNY Progyny	$1.29B	1.90	$0.73 per share	42.76	$5.99 per share	5.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$95.91M	$5.70	20.43	17.15	1.56	7.13%	9.96%	7.62%	N/A
CLOV Clover Health Investments	-$85.55M	-$0.12	N/A	N/A	N/A	-2.58%	-16.52%	-9.28%	8/5/2026 (Estimated)
EHAB Enhabit	-$4.60M	-$0.09	N/A	21.56	N/A	-0.30%	7.24%	3.48%	8/5/2026 (Estimated)
PGNY Progyny	$58.52M	$0.77	40.74	22.90	2.50	5.23%	13.34%	9.03%	8/6/2026 (Estimated)

Latest EHAB, PGNY, CLOV, and ADUS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	PGNY Progyny	$0.3348	N/A	N/A	N/A	$348.63 million	N/A
8/5/2026	Q2 2026	CLOV Clover Health Investments	$0.0386	$0.05	+$0.0114	$0.05	$728.27 million	$743.17 million
8/3/2026	Q2 2026	ADUS Addus HomeCare	$1.70	$1.73	+$0.03	$1.49	$376.24 million	$377.41 million
5/7/2026	Q1 2026	EHAB Enhabit	N/A	$0.36	N/A	$0.36	N/A	$264.80 million
5/7/2026	Q1 2026	PGNY Progyny	$0.2560	$0.50	+$0.2440	$0.29	$326.47 million	$328.50 million
5/6/2026	Q1 2026	CLOV Clover Health Investments	$0.07	$0.05	-$0.02	$0.05	$714.89 million	$749.19 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
CLOV Clover Health Investments	N/A	N/A	N/A	N/A	N/A
EHAB Enhabit	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.05	1.69	1.83
CLOV Clover Health Investments	N/A	1.33	1.33
EHAB Enhabit	0.70	1.56	1.56
PGNY Progyny	N/A	2.13	2.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
CLOV Clover Health Investments	19.77%
EHAB Enhabit	N/A
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.10%
CLOV Clover Health Investments	23.51%
EHAB Enhabit	3.40%
PGNY Progyny	9.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	50,659	18.67 million	17.90 million	Optionable
CLOV Clover Health Investments	680	526.68 million	402.86 million	Optionable
EHAB Enhabit	10,800	51.23 million	49.48 million	Optionable
PGNY Progyny	310	78.33 million	70.58 million	Optionable

EHAB, PGNY, CLOV, and ADUS Headlines

Recent News About These Companies

Progyny, Inc. $PGNY Shares Bought by Segall Bryant & Hamill LLC

August 5 at 5:11 AM | marketbeat.com

First Trust Advisors LP Has $6.60 Million Stock Position in Progyny, Inc. $PGNY

August 3 at 3:36 AM | marketbeat.com

Arrowstreet Capital Limited Partnership Lowers Stake in Progyny, Inc. $PGNY

August 3 at 3:04 AM | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Receives Consensus Recommendation of "Moderate Buy" from Analysts

August 2 at 2:28 AM | americanbankingnews.com

Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from Analysts

August 2 at 2:28 AM | marketbeat.com

Healthcare of Ontario Pension Plan Trust Fund Purchases Shares of 183,166 Progyny, Inc. $PGNY

July 31, 2026 | marketbeat.com

Progyny's (PGNY) Equal Weight Rating Reiterated at Barclays

July 31, 2026 | americanbankingnews.com

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

July 30, 2026 | zacks.com

Progyny (PGNY) to Post Earnings on Thursday

July 30, 2026 | marketbeat.com

OMERS ADMINISTRATION Corp Raises Position in Progyny, Inc. $PGNY

July 30, 2026 | marketbeat.com

Progyny (NASDAQ:PGNY) Downgraded to Hold Rating by Barclays

July 29, 2026 | marketbeat.com

Fifth Third Bancorp Increases Stock Position in Progyny, Inc. $PGNY

July 27, 2026 | marketbeat.com

Principal Financial Group Inc. Purchases 78,198 Shares of Progyny, Inc. $PGNY

July 26, 2026 | marketbeat.com

BTIG Research Raises Progyny (NASDAQ:PGNY) Price Target to $40.00

July 26, 2026 | americanbankingnews.com

Progyny (NASDAQ:PGNY) Cut to "Buy" at Wall Street Zen

July 25, 2026 | marketbeat.com

Progyny (NASDAQ:PGNY) Price Target Raised to $40.00 at BTIG Research

July 24, 2026 | marketbeat.com

76,500 Shares in Progyny, Inc. $PGNY Bought by SEB Asset Management AB

July 24, 2026 | marketbeat.com

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

July 23, 2026 | globenewswire.com

Canaccord Genuity Group Forecasts Strong Price Appreciation for Progyny (NASDAQ:PGNY) Stock

July 21, 2026 | marketbeat.com

Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors

July 19, 2026 | fool.com

5 Top Stocks With Relative Price Strength to Buy Right Now

July 17, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

EHAB, PGNY, CLOV, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

$116.46 +2.80 (+2.46%)

Closing price 04:00 PM Eastern

Extended Trading

$116.19 -0.27 (-0.23%)

As of 07:34 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Clover Health Investments NASDAQ:CLOV

$4.14 -0.13 (-3.04%)

Closing price 04:00 PM Eastern

Extended Trading

$4.52 +0.38 (+9.18%)

As of 07:59 PM Eastern

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Enhabit NYSE:EHAB

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Progyny NASDAQ:PGNY

$31.37 -0.11 (-0.35%)

Closing price 04:00 PM Eastern

Extended Trading

$31.37 0.00 (0.00%)

As of 07:34 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EHAB, PGNY, CLOV, and ADUS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EHAB, PGNY, CLOV, and ADUS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EHAB, PGNY, CLOV, and ADUS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

EHAB, PGNY, CLOV, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

Clover Health Investments NASDAQ:CLOV

Enhabit NYSE:EHAB

Progyny NASDAQ:PGNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EHAB, PGNY, CLOV, and ADUS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EHAB, PGNY, CLOV, and ADUS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EHAB, PGNY, CLOV, and ADUS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

EHAB, PGNY, CLOV, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

Clover Health Investments NASDAQ:CLOV

Enhabit NYSE:EHAB

Progyny NASDAQ:PGNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools